Market Tracker

03/31 5:16pm ET

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

31.26
Delayed Data
As of 4:00pm ET
 +0.96 / +3.17%
Today’s Change
11.34
Today|||52-Week Range
39.80
-18.91%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close30.30
Today’s open29.84
Day’s range29.70 - 31.77
Volume35,325
Average volume (3 months)28,650
Market cap$436.9M
Dividend yield2.14%
Data as of 4:00pm ET, 03/31/2015

Growth & Valuation

Earnings growth (last year)-108.57%
Earnings growth (this year)+88.41%
Earnings growth (next 5 years)--
Revenue growth (last year)-81.80%
P/E ratioNM
Price/Sales36.10
Price/Book0.66

Competitors

 Today’s
change
Today’s
% change
SGYPSynergy Pharmaceutic...+0.13+2.90%
XOMAXOMA Corp-0.09-2.41%
IGIGI Laboratories Inc-0.29-3.43%
HRTXHeron Therapeutics I...+0.12+0.83%
Data as of 4:01pm ET, 03/31/2015

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$10.38
Annual revenue (last year)$1.7M
Annual profit (last year)-$27.4M
Net profit margin-1,571.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts